research

COLON CARCINOMA: PECULIARITIES IN NIGERIA. A REVIEW.

COLON CARCINOMA: PECULIARITIES IN NIGERIA.  A REVIEW.

BY: EROMOSELE BENJAMIN O.

AS AT TIME OF WRITING, 2ND YEAR CLINICAL STUDENT, COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, IBADAN.

EROMOSELE BENJAMIN OSEIWE
Department of Medicine and Surgery,
College of Medicne,
University of Ibadan,
Ibadan.
PMB 5116,
Oyo State,
Nigeria.

 

ABSTRACT

BACKGROUND

Typically referred to as a disease of Caucasians, the incidence of colon carcinoma is growing in Nigeria. In this review, factors that may be accounting for this trend are looked at, as well as the peculiarities of the disease in Nigeria and Africa at large.

Colon carcinoma in Nigeria comes with its peculiarities such as, late presentation; such that most cases present at an advanced stage with incurable disease, increasing adoption of ‘Western’ diets and lifestyle; such as, consumption of high fat, low fibre diet, and reduced physical activity, which is suspected to be responsible for the increasing incidence of the disease, and a paucity of polyposis coli syndromes.

The aim of this review is to emphasize;

  • that colon carcinoma is not a disease of only Caucasians and that the incidence is even increasing among native Africans
  • the peculiarities of this disease among Nigerians in particular and Africans at large
  • the pointers to early diagnosis
  • preventive measures to this potential epidemic

MATERIALS AND METHODS

The materials used in this review article comes from studies and publications on colorectal carcinoma.

KEYWORDS

Colon, carcinoma, peculiarities and review.

INTRODUCTION

Colon carcinoma in traditional descriptions, is said to be uncommon among native Africans. Once the 10th most common malignancy in men from the Ibadan cancer registry four decades ago (1960 to 1969), now holds as the fourth most common malignancy [1]. This shows an increasing incidence.

Even with an increasing incidence, reports estimate that about 6 to 25 patients present annually in Nigerian tertiary health care centers[2-9]. This shows that it is still relatively uncommon compared to other westernized societies. Awarness must be put in place to halt this potential ‘outbreak’, considering resource constraint on the part of the government in solving issues such as this in Africa, with Nigeria in particular. This is further complicated by the fact that most Nigerian patients present late with advanced disease, with a significant proportion in comparison to Caucasian cases, being the mucin-producing adenocarcinoma which carries a worse prognosis [10].

In contrast to other westernized societies, there is a paucity of polyposis coli syndromes among Nigerians [10] such as Lynch syndrome which confers a hereditary predisposition to colon cancer. In Nigeria only four cases of adenomatous polyposis have been reported in the last thirty five years [11,12,13,14]. The mean age incidence of colon carcinoma in Nigeria is 41 years, with Ibadan as reference [15], with an incidence rate of 3.4/100,000[16], the increasing incidence may be attributed to an increasing adoption of westernized lifestyle, increasing life expectancy; due to an increasing access to better health care, since colon carcinoma is sometimes referred to as a disease of aging[17], among other reasons.

DISCUSSION

With an increasing incidence of colon carcinoma in Nigeria, the peculiarities of the typical Nigerian picture of colon carcinoma are discussed below

Pathogenesis

The carcinogenesis of colonic carcinoma among Nigerians is somewhat controversial. The typical adenoma-carcinoma sequence seems unlikely among Nigerians [4,15,18,19]. This is supported by the fact that studies show that it takes fifteen to twenty years for malignant change to occur in an adenoma[9,20], making it unlikely in Nigerians since the age incidence of clinical disease is relatively commoner among the younger age group. The microsatellite instability theory holds true more commonly for hereditary nonpolyposis colorectal carcinoma [21], which is rare among Africans.

This raises the suggestion that most cases of colon carcinoma in Nigeria occur sporadically, with an adequate environmental influence.

Presentation

The clinical presentation depends on the site affected. The most common site in Nigeria appears to be the caecum [10], which may present as an abdominal mass [17]. In right sided disease, presentation is usually that of an iron deficiency anemia due to chronic blood loss. In left sided disease, the features are those of obstruction such as change in bowel habit, chronic constipation; since the stenosing variant of colon carcinoma seems more common here [17]. In the transverse colon, the features here are determined by the proximity to either the right or left side. If closer to the right, features are similar to right sided disease and if close to the left; features are similar to those of left sided disease. Bleeding per rectum, hemorrhoids due to obstruction of the superior rectal vein [17] and tenesmus may also be seen. It is also noteworthy that most patients present late in Nigeria. Orthodox and traditional means are usually first sought before hospital presentation, causing most patients to present late with advanced and incurable disease. Most times in this case, palliative care may be offered with chemotherapy. In operable cases, surgery may be offered.

In this group of patients features in keeping with advanced disease such as weight loss due to elaboration of cachexin (TNF alpha), malignant peritonitis, colo-vesical fistula, colo-vaginal fistula and a host of other features due to local invasion, tumor infiltration and distant metastasis are seen.

Histologic Subtype and Mode of Spread

The mucin-producing adenocarcinoma has a higher proportion among native Africans compared to Caucasuians (it occurs in native Africans in a percentage of thirteen to twenty; while it occurs among Caucasians in a percentage of four to six) [34]. It is also known to carry a bad prognosis [10]. It is defined as a tumor displaying extracellular mucin in more than 50% of the tumor volume [22]. New evidence is showing that mucin-producing adenocarcinoma may have a distinct biological and genetic identity compared with non-mucinous adenocarcinoma [23,24]. Patients with mucin-producing adenocarcinoma are usually younger [25,26]; which most Nigerian cases fall into due to average life span demographics. In addition, these tumors may have distinct mutations and cytogenic abnormalities [23,27], and may be less likely to respond to chemotherapy[28-30]. These tumors are commonly right sided [31-33], and associated with advanced disease [24,25,31,32], which holds true for most cases in Nigeria

Spread may be by;

  • Direct infiltration, usually by a transverse means to encircle the bowel wall. Microscopically it does not spread beyond 5cm of the macroscopic edge longitudinally [17]. Thus the affected segment must be resected at least 5cm beyond the tumor edge [17].
  • Lymphatic spread first to the paracolic lymph nodes and through the intermediate nodes to the inferior and superior mesenteric lymph nodes [17]. The frequency of lymph node metastases is directly related to the degree of penetration of the intestinal wall and the histologic grade of the malignancy and not necessarily the size of the primary lesion [17].
  • Spread through the blood stream is usually through the inferior or superior mesenteric veins, and the portal vein; to the liver (33%), less frequently to the lungs (22%), adrenals (11%), kidneys and bone (11%) and the brain.[17]
  • Transperitoneal spread which may result in malignant peritonitis with ascites.

Risk Factors

The role of diet in the epidemiology of colon carcinoma is one that has been extensively studied [34]. Most traditional Nigerian diets are said to be protective due to its high fibre, mineral and vitamin content from locally available fruits and vegetable, high spice and pepper content [34], which translates to higher antioxidant levels. Local Nigerian diets are majorly carbohydrate based which has been shown to have protective effects too [34]. The high sunlight exposure Nigeria enjoys [34], appears to afford us more vitamin D, which is colon carcinoma protective.

The increasing incidence of colon carcinoma may be traced to adoption of westernized diets due to affluence. Most westernized diets have a low fibre and high fat content, which has been repeatedly shown to be a risk factor for colon carcinoma [37,38]. Intake of fruits and vegetables is reducing among Nigerians, with a concomitant reduced intake of minerals, vitamins, antioxidants and fibre contained in them, which are cancer protective [34].

The increasing adoption of tobacco smoking among Nigerians may also account for an increasing incidence of colon carcinoma [39].

Excessive alcohol intake has also been shown to be a risk factor for colon carcinoma and gastro-intestinal cancers in general, it is thought to be due to production of acetaldehyde which is a known carcinogen [35,36]. Due to increasing affluence among Nigerians, alcohol consumption is on increase.

Adoption of sedentary lifestyles with reduced physical activity is a risk factor for obesity. Obesity has been linked with colon carcinoma development [37,38]. Sedentary lifestyles are associated with less sunlight exposure, which amounts to less vitamin D in the body, with therefore an increased colon carcinoma risk, since vitamin D is known to be colon carcinoma protective [34].

The adoption of westernized lifestyle has been linked to increasing affluence among Nigerians and an ever increasing influx of foreign processed foods; most of which are associated with cancer risks, from developed countries into Nigeria.

Treatment options

Modality of treatment to be used is governed mainly by the stage of presentation and site affected.

Surgical treatment [17]

  • Caecum, ascending colon and hepatic flexure; right hemi-colectomy, that is resection of the last 15cm of the terminal ileum, ascending colon and proximal two-thirds of the transverse colon with ileo—transverse anastomosis
  • Transverse colon; resection of the transverse colon and both flexures
  • Splenic flexure; left hemi-colectomy that is resection of the distal colon and distal two-thirds of the transverse colon.
  • Descending colon; same as splenic flexure, but a more radical resection with removal of the pelvic colon is preferable.
  • Pelvic colon; pelvic colectomy with or without left hemicolectomy

Treatment is most commonly by open abdominal surgery using diathermy, stiches and staples.

Radiotherapy

It is given preoperatively if the tumor is tethered or with evidence of extra-peritoneal spread and/or positive lymph nodes or post-operatively if a tumor turns out to be Dukes’ B2 or C [17]. Radiotherapy may also be offered as a palliative measure in advanced disease.

Chemotherapy

5- fluoro uracil, an antimetabolite cancer chemotherapeutic agent is the major agent used. Leucovorin is usually added as an adjunct due to the associated risk of bone marrow suppression which may cause severe neutropenia. Other agents which may be used in combination with 5-flouro uracil, include the platinum based chemotherapeutic agent, oxaliplatin and irinotecan, a topoisomerase 1 inhibitor.

Bevacizumab is a humanized monoclonal IgG antibody which binds and neutralizes vascular endothelial growth factor (VEGF), which has shown so much promise with its use in the western societies, but with limited use in Nigeria due to cost implications.

Screening

Even though not yet realistic in this environment due to relatively low incidence rate, it is commonly practiced in high risk groups in the western societies, where it has become of public health concern. It includes;

  • Fecal occult blood sampling
  • Sigmoidoscopy
  • Colonoscopy

  

Conclusion

Colon carcinoma a major cause of morbidity in the developed climes and is gradually taking its root in Nigeria in particular, and Africa as a whole. This has been largely due to adoption of westernized lifestyle due to increasing affluence among Nigerians. Control and preventive measure must be put in place to stem this growing problem which has the potential to take its toll in Africa, being a resource poor environment.

Acknowledgement

I want to specially acknowledge Dr. D.O. Irabor; Consultant Gastro-Intestinal Surgeon, who has spurred my interest in the field of gastro-intestinal surgery due to his prowess as a teacher and great skill as a surgeon. I also appreciate him, for accepting to be the Supervising Consultant of this review article, and for being my mentor and role model.

References

  1. 1. N. Okobia, “Cancer care in sub-Saharan Africa- urgent need for population-based cancer registries,” The Ethiopian Journal of Health Development, vol. 17, pp. 89-98, 2003.
  2. O. O. Adekunle and  A.  A.  Abioye,  “Adenocarcinoma  of  the  large  bowel  in  Nigerians:  a  clinicopathologic  study,”  Diseases  of  the  Colon  and Rectum, vol. 23, no. 8, pp. 559–563, 1980.
  3. Y. Iliyasu,  J. K. Ladipo, E. E. U. Akang, C. A. Adebamowo, O. G. Ajao, and P. U. Aghadiuno, “A  twenty-year review of malignant colorectal neoplasms  at  University  College  Hospital,  Ibadan,  Nigeria,”  Diseases  of  the  Colon  and  Rectum,  vol.  39,  no.  5,  pp.  536–540,  1996.
  4. O. O.  Akute,  “Colorectal  carcinoma  in  Ibadan,  Nigeria:  a  20-year  survey—1971  to  1990,”  Hepato-Gastroenterology,  vol.  47,  no.  33,  pp.  709–713, 2000.
  5. D. C.  Nwafo  and  J.  O.  Ojukwu,  “Malignant  disease  of  the  colon,  rectum,  and  anus  in  Nigerian  Igbos,”  Annals  of  the  Royal  College  of Surgeons of England, vol. 62, no. 2, pp. 133–135, 1980.
  6. A. Z.  Sule,  B. M. Mandong,  and D.  Iya,  “Malignant  colorectal  tumours:  a  ten  year  review  in  Jos, Nigeria,” West  African  Journal  of  Medicine, vol. 20, no. 4, pp. 251–255, 2001.
  7. S. T. Edino, A. Z. Mohammed, and O. Ochicha, “Characteristics of colorectal carcinoma in Kano, Nigeria: an analysis of 50 cases,” Nigerian Journal of Medicine, vol. 14, no. 2, pp. 161–166, 2005.
  8. D. O.  Akinola  and  A.  O.  Arigbabu,  “Pattern  and  presentation  of  large  bowel  neoplasms  in  Nigerians,”  Central  African  Journal  of  Medicine, vol. 40, no. 4, pp. 98–102, 1994.
  9. A. A.  Adesanya  and  J.  T.  da  Rocha-Afodu,  “Colorectal  cancer  in  Lagos:  a  critical  review  of  100  cases,”  The  Nigerian  Postgraduate  Medical Journal, vol. 7, no. 3, pp. 129–136, 2000.
  10. Irabor D., Adedeji O.A., “Colorectal cancer in Nigeria: 40 years on. A review” Eur J Cancer Care (Engl). 2009 Mar;18(2):110-5. doi: 10.1111/j.1365-2354.2008.00982.x.
  11. O. B. Alese  and  D.  O.  Irabor,  “Adenomatous  polyposis  coli  in  an  elderly  female  Nigerian,”  Ghana  Medical  Journal,  vol.  43,  pp.  139–141, 2009.
  12. O. O. Adekunle and G. O. Ajao, “Colorectal cancer in adolescent Nigerians,” Scandinavian Journal of Gastroenterology, Supplement, vol. 21, no. 124, pp. 183–186, 1986.
  13. S. U.  Udofot,  M.  D.  Ekpo,  and  M.  I.  Khalil,  “Familial  polyposis  coli:  an  unusual  case  in  West  Africa,”  Central  African  Journal  of  Medicine, vol. 38, no. 1, pp. 44–48, 1992.
  14. B. J.  Olasode  and  O.  A.  Olasode,  “Missed  diagnosis—adenomatous  polyposis  coli,”  The Central African  Journal  of Medicine,  vol.  43,  no.  11, article 339, 1997.
  15. D. O. Irabor,  A.  Arowolo,  and  A.  A.  Afolabi,  “Colon  and  rectal  cancer  in  Ibadan,  Nigeria:  an  update,”  Colorectal Disease,  vol.  12,  pp.  e43–e49, 2010.7
  16.  I.  Segal,  “Rarity  of  colorectal  adenomas  in  the  African  black  population,”  European  Journal  of  Cancer  Prevention,  vol.  7,  no.  5,  pp.  387–391,1998.
  1. E.A. Badoe, E.Q. Archampong, J.T. da Rocha-Afodu. Principles of Practice of Surgery including pathology in the tropics. Ghana publishing Corporation. 4th edition. Pages 721-728. Published in 2009.
  2. H. Boytchev, S.  Marcovic,  and  G.  J.  Oettle,  “The  characteristics  of  large  bowel  cancer  in  the  low-risk  black  population  of  the Witwatersrand,”  Journal  of  the  Royal  College  of  Surgeons  of  Edinburgh,  vol.  44,  no.  6,  pp.  366–370,  1999.
  3. O. G.  Ajao,  M.  O.  Adenuga,  and  J.  K.  Ladipo,  “Colorectal  carcinoma  in  patients  under  the  age  of  30  years:  a  review  of  11  cases,”  Journal  of the Royal College of Surgeons of Edinburgh, vol. 33, no. 5, pp. 277–279, 1988.
  4. J. Sack and  J.  M.  Rothman,  “Colorectal  carcinoma:  natural  history  and  management,”  Hospital Physician,  vol.  36,  pp.  64–73,  2000.
  5. Kumar V., Abbas A., Fausto N., Mitchell R. Robbins Basic pathology. Saunders Elsevier Publishing. 8th edition. Pages 620-621. Published in 2007.
  6. Mirna H Farhat, Kassem A Barada, Ayman N Tawil, Doha M Itani, Hassan A Hatoum, and Ali I Shamseddine, World J Gastroenterol. 14(45): 6981–6985. Dec 7 2008.
  7. Zhang H, Evertsson S, Sun X. Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. In J Oncol. 1999;14:1057–1061.
  8. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol. 73:70–74. 2000.
  9. Wu CS, Tung SY, Chen PC, Kuo YC. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol. 1996;11:77–81.
  10. Suma KS, Nirmala V. Mucinous component in colorectal carcinoma–prognostic significance: a study in a south Indian population. J Surg Oncol. 1992;51:60–64.
  11. Messerini L, Vitelli F, De Vitis LR, Mori S, Calzolari A, Palmirotta R, Calabro A, Papi L. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables. J Pathol. 1997;182:380–384.
  12. Negri FV, Wotherspoon A, Cunningham D, Norman AR, Chong G, Ross PJ. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol. 2005;16:1305–1310.
  13. Glasgow SC, Yu J, Carvalho LP, Shannon WD, Fleshman JW, McLeod HL. Unfavourable expression of pharmacologic markers in mucinous colorectal cancer. Br J Cancer. 2005;92:259–264.
  14. Takemura M, Osugi H, Lee S, Kaneko M, Tanaka Y, Fujiwara Y, Nishizawa S, Iwasaki H. [Choice of chemotherapeutic drugs for colorectal cancers by DPD and OPRT activities in cancer tissues] Gan To Kagaku Ryoho.
  15. Papadopoulos VN, Michalopoulos A, Netta S, Basdanis G, Paramythiotis D, Zatagias A, Berovalis P, Harlaftis N. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol. 2004;8 Suppl 1:s123–s125.
  16. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum J Surg Oncol. 2000;75:103–107.
  17. Kang H, O’Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48:1161–1168.
  18. David Omoareghan Irabor. Colorectal Carcinoma: Why Is There a Lower Incidence in Nigerians When Compared to Caucasians? Journal of Cancer Epidemiology Volume 2011 (2011), Article ID 675154
  19. Salaspuro M. “Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers”. Scand J Gastroenterol. 2009;44(8):912-25.
  20. Lachenmeier DW , Kanteres F, Rehm J. Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism. Addiction. 2009 Apr;104(4):533-50.
  21. Bardou M , Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013 Jun;62(6):933-47.
  22. E. E. Frezza, M. S. Wachtel, and M. Chiriva-Internati. “Influence of obesity on the risk of developing colon cancer”. Gut. 2006 Feb; 55(2): 285-291
  23. Chao A., Thun M.J., Jacobs E.J., Henley S.J. et al. “ Cigarrette Smoking and Colorectal Cancer Mortality in the Cancer Prevention Study II”. J Natl Cancer Inst (2000) 92 (23): 1888-1896.
Read More